Leone, A.; Colamaria, A.; Fochi, N.P.; Sacco, M.; Landriscina, M.; Parbonetti, G.; de Notaris, M.; Coppola, G.; De Santis, E.; Giordano, G.;
et al. Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era. Biomedicines 2022, 10, 1927.
https://doi.org/10.3390/biomedicines10081927
AMA Style
Leone A, Colamaria A, Fochi NP, Sacco M, Landriscina M, Parbonetti G, de Notaris M, Coppola G, De Santis E, Giordano G,
et al. Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era. Biomedicines. 2022; 10(8):1927.
https://doi.org/10.3390/biomedicines10081927
Chicago/Turabian Style
Leone, Augusto, Antonio Colamaria, Nicola Pio Fochi, Matteo Sacco, Matteo Landriscina, Giovanni Parbonetti, Matteo de Notaris, Giulia Coppola, Elena De Santis, Guido Giordano,
and et al. 2022. "Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era" Biomedicines 10, no. 8: 1927.
https://doi.org/10.3390/biomedicines10081927
APA Style
Leone, A., Colamaria, A., Fochi, N. P., Sacco, M., Landriscina, M., Parbonetti, G., de Notaris, M., Coppola, G., De Santis, E., Giordano, G., & Carbone, F.
(2022). Recurrent Glioblastoma Treatment: State of the Art and Future Perspectives in the Precision Medicine Era. Biomedicines, 10(8), 1927.
https://doi.org/10.3390/biomedicines10081927